Thromboembolic prophylaxis and survival after trauma;Tromboembolijska profilaksa i preživljenje nakon ozljede

Acta Medica Croatica

Volumn 57, Issue 2, 2003, Pages 99-103

  Car, Dolores ^a   Bajs, Ivana Dovžak ^a   Lajtman, Zoran ^b   Car, Zdravko ^c   Cvjetko, Ivan ^a  

^a Merkur University Hospital ^*

^b KBC Zagreb   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Pulmonary embolism; Thromboembolism; Thrombolism prophylaxis; Trauma

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; REVIPARIN;

ARTICLE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MORTALITY; ORTHOPEDIC SURGERY; PROPHYLAXIS; SURVIVAL; THROMBOEMBOLISM; TRAUMATOLOGY; INJURY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SURVIVAL RATE;

HUMANS; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; SURVIVAL RATE; THROMBOEMBOLISM; WOUNDS AND INJURIES;

EID: 0038678054     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Heit JA, Mohr DN, Peterson TM, O'Fallon WM, Melton LjIII. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case control study. Arch Intern Med 2000; 160: 809-15.
2. Heit JA, Silverstein MD, Mohr DN i sur. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001; 86: 452-63.
3. Geerts WH, Code KJ, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med 1994; 331: 1601-6.
4. Caprini JA, Arcelus JR, Reyna JJ. Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol 2001; 38(suppl 5): 12-19.
5. Clagett GP, Anderson FA, Geerts W i sur. Prevention of venous thromboembolism. Chest 1998; 114 (suppl 5): 531-60.
6. Piement GD. Orthopedics 1995; 18 (suppl): 12-14.
7. Kearon C, Salzman E, Hirsh J. Epidemiology, pathogenesis and natural history of venous thrombosis. U: Colman R, Hirsh J, Marder JV, Clowes AW, George JN. Hemostasis and Thrombosis. Philadelphia: Lippincott, Wil- liams & Wilkins, 2001.
8. Rodger M, Wells PS. Diagnosis of pulmonary embolism. Vessels 2001; 103: 225-8.
9. Bergqvist D, Jendteg S, Johansen L, Persson W, Odegaard K. Cost of long term complications of deep vein thrombosis of the lower extremities: an analysis of defined patient population in Sweden. Ann Intern Med 1997; 126: 454-7.
10. Bernardi E, Bagatella P, Frulla M, Simioni P, Prandoni P. Postthrombotic syndrome: incidence, prevention, and management. Semin Vasc Med 2001; 1: 71-9.
11. Cohen AT. Applying risk assessment models in orthopedic surgery: effective risk stratification. Blood Coagulation and Fibrinolysis 1999; 10 (suppl 2): 63-70.
12. Nicolaides AN, Bergqvist D, Hull R. Prevention of venous thromboembolism. International concensus statement. Int. Angiol 1997; 16: 3-38.
13. Geerts WH, Heit JA, Clagget GP i sur. Prevention of venous thromboembolism. Chest 2001; 119: 132-175.
14. Kearon C. Natural hystory of venous thromboembolism. Semin Vasc Med 2001; 1: 27-37.
15. Storti S, Crucitti P, Cina G. Risk factors and prevention of venous thromboembolism. Rays 1996; 21: 439-60.
16. Dahl OE, Aspelin T, Lyberg T. The role of bone traumatization in te initiation of proximal deep vein thromboses curing cemented hip replacement in pigs. Blood Coagul Fibrinolysis 1995; 6: 709-17.
17. Eriksson B, Eriksson E, Gyzander E i sur. Thrombosis after hip replacement. Acta Orthop Scand 1989; 60: 159-63.
18. Schlag G, Redl H. Mediators of injury and inflammation. World J Surg 1996; 20(4): 406-10.
19. Roumen RMH, Redl H, Schlag G i sur. Inflammatory mediator in relation to the developnemt of multiple organ failure in patients after severe blunt trauma. Crit Care Med 1995; 23: 474-80.
20. Muchart DJ, Bhagwanje S. American College of Chest Physician Society of Critical Care Medicine Consensus Conference definitions of the systremic inflammatory responce syndrome and allied disorders in relation to criticaly injured patients. Crit Care Med 1997; 25: 1789-95.
21. Geller ER. Shock and resuscitation. Mc Graw Hill, USA 1993.
22. Seifried E, Lampl L, Seidl C i sur. Alterations of coagulation and fybrinolysis during the preclinical phase after polytrauma. U: Müller-Berghaus G, Madlener K, Blombäck M, ten Cate JW. DIC. Amsterdam: Excerpta medica, 1993, 147-157.
23. Petersen LC. Valentin and U. Hedner Regulation of the extrinsic pathway system in health and disease: The role of factor VIIa an tissue factor pathway inhibitor. Vessels 1995; 79: 1.
24. O'Malley KF, Ross SE. Pulmonary embolism in major trauma patients. J Trauma 1990; 30: 748-50.
25. Meignan M, Rosso M, Gauthier H i sur. Silent lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep vein thrombosis. Arch Intern Med 2000; 160 (24): 159-64.
26. Hass S. Thromboembolism prophylaxis: Special Concensus Document. S Clin Appl Thrombosis/Hemostasis 2001; 7 (3): 171-7.
27. Geerts WH, Jay RM, Code KI i sur. A comparison of low-dose heparin with low-molecular- weight-heparin. N Engl J Med 1996; 335: 701-7.
28. Knudson MM, Collins JA, Goodman SB i sur. Thromboembolism following multiple trauma. J Trauma 1992; 29. 32: 2-11.
29. Geerts WH, Code KI, Jay JM i sur. A prospective study of venous thromboembolism after major trauma. N Engl J Med 1994; 331: 1601-6.
30. Enderson BL, Chen JP, Robinson R, Maull KI. Fibrinolysis in multi-system trauma patients. J Trauma 1991; 31: 1240-6.
31. Prandoni P, Sabbion P, Tanduo C, Errigo G, Zanon E, Bemardi E. Prevention of venous thromboembolism in high-risk surgical and medical patients. Semin Vasc Med 2001; 1: 61-70.
32. Gunduz S, Ogur E, Mohur H i sur. Deep vein thrombosis in spinal cord injured patients. Paraplegia 1993; 31: 606-10.
33. Green D. Prophylaxis of venous thromboembolism in spinal cord-injured patients. Chest 1992; 102 (suppl): 649-51.
34. Green D, Lee MY, Lim AC i sur. Prevention of thromboembolism after spinal cord injury using low molecular weight heparin. Ann Intern Med 1990; 113: 571-4.
35. Montgomery KD, Geerts WH, Potter HG i sur. Thromboembolic complications in patients with pelvic trauma. Clin Orthop 1996; 329: 68-87.
36. Abelseth, G, Buckley RE, Pineo GE i sur. Incidence of deep-vein thrombosis in patients with fractures of the lower extremity distal to the hip. J Orthop Trauma 1996; 10: 230-5.
37. Snook GA, Chrisman OD, Wilson TX. Thromboembolism after surgical treatment of hip fractures. Clin Orthop 1981; 155: 21-4.
38. Lotke PA, Steinberg ME, Ecker ML. Significance of deep vein thrombosis in the lower extremity after total joint arthroplasty. Clin Orthop 1994; 299: 25-30.
39. Pellegrini VD, Clement D, Lush-Ehmann C i sur. Natural hystory of thromboembolic disease after total hip arthroplasty. Clin Orthop 1996; 333: 27-40.
40. Cade JF. High risk of the critically ill for venous thromboembolism. Crit Care Med 1982; 10: 448-50.
41. Samama MA, Cohen AT, Darmon JY i sur. A comparison of enoxaparin with the placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med 1999; 341: 793-800.
42. Merli GJ, Crabe S, Doyle L i sur. Mechanical plus pharmacological prophylaxis for deep vein thromboses in acute spinal cord injury. Paraplegia 1992; 30: 558-62.
43. Pasquale M, Fabian TC, and the EAST ad hoc Committee on Practice Management Guideline Development. Practice menagement guidelines for venous thromboembolism in trauma patients. J Trauma 1998; 43: 947-956.
44. Fareed J, Hass S, Sasahara A. Past, present and future considerations on low molecular weight heparin differentiation. Semin Thromb Hemost 1999; 25 (suppl 3): 145-7.
45. Green, D, Lee MY, Ito VY i sur. Fixed - versus adjusted-dose heparin in prophylaxis of thromboembolism in spinal cord injury. JAMA 1988; 260: 1255-8.
46. Brasel KJ, Borgstrom DC, Weigelt JA. Cost-effective prevention of pulmonary embolus in high risk trauma patients. J Trauma 1997; 42: 456-62.